Effects of a novel orally effective V1-receptor antagonist, OPC-21268, on AVP-induced sympathoinhibition.

Hiroyuki Masaki,Takahiro Imaizumi,Seiki Harada,Michiko Momohara,Yoshitaka Hirooka,Akira Takeshita

Effects of a novel orally effective V1-receptor antagonist, OPC-21268, on AVP-induced sympathoinhibition.

1993

Hiroyuki Masaki
Takahiro Imaizumi
Seiki Harada
Michiko Momohara
Yoshitaka Hirooka
Akira Takeshita

Arginine vasopressin (AVP) plays as important role in control of circulation and may be involved in pathophysiology of cardiovascular diseases. Recently a novel oral V1-receptor antagonist, OPC-212...

Keywords:

Pathophysiology
Baroreflex
Endocrinology
Antagonist
Arginine
Internal medicine
Vasopressin
Vasopressin receptor
Renal nerve
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations